Skip to content

Effect of a bioactive solution on the duration of diarrhoea in adult and paediatric patients

Assessment of a bioactive polyphenol solution on the duration of acute diarrhoea in adult and paediatric patients: a randomised double-blind placebo-controlled crossover study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN57765025
Enrollment
200
Registered
2015-01-21
Start date
2010-09-14
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute diarrhoea (for less than 48 hours) Digestive System Diarrhoea

Interventions

1. Oral rehydration solution and bioactive solution on day 1 and then oral rehydration solution and water (placebo) on day 2 2. Oral rehydration solution and water (placebo) on day 1 a

Sponsors

LiveLeaf Inc
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. 5–80 years old 2. Diarrhoea for less than 48 hours

Exclusion criteria

Exclusion criteria: 1. History of uncontrolled emesis 2. Grossly bloody stool 3. Fever 4. Clinical signs of a coexisting acute systemic illness (e.g., meningitis, sepsis or pneumonia) 5. Underlying chronic disease (e.g., heart disease, cystic fibrosis or diabetes) 6. Food allergies or other chronic gastrointestinal diseases 7. Use of probiotic agents in the previous 3 weeks or antibiotics or anti-diarrhoeal medications including over-the-counter and herbal substances in the previous 2 weeks 8. Generalised cachexia 9. Any signs of internal bleeding or drug abuse 10. Any condition, assessed with a standard of care, to cause unnecessary risk if participant given oral rehydration solution alone 11. Unable or unwilling to provide informed consent

Design outcomes

Primary

MeasureTime frame
Resolution to diarrhoea, assessed as the time from ingestion of the solution to when an individual produced a stool with a Bristol Stool Scale ranking of 4 or less.

Secondary

MeasureTime frame
1. Defecation urgency, ranked from 0 (none) to 10 (extreme) at the various time intervals by patients (adults) and caregivers (for children) 2. Bloating or gas, ranked from 0 (none) to 10 (extreme) at the various time intervals by patients (adults) and caregivers (for children) 3. Abdominal pain at 30, 60, 90 and 120 minutes after consumption of the solutions on day 1 and day 2; pain was ranked from 0 to 10 on the Visual Analogue Scale

Countries

Nicaragua

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026